NewEdge Wealth LLC Sells 18,855 Shares of CVS Health Corporation $CVS

NewEdge Wealth LLC reduced its holdings in shares of CVS Health Corporation (NYSE:CVS) by 52.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 16,899 shares of the pharmacy operator’s stock after selling 18,855 shares during the period. NewEdge Wealth LLC’s holdings in CVS Health were worth $1,327,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. Corundum Trust Company INC purchased a new stake in CVS Health in the 3rd quarter worth $29,000. Front Row Advisors LLC raised its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the last quarter. Twin Peaks Wealth Advisors LLC purchased a new position in shares of CVS Health in the second quarter valued at approximately $36,000. Finally, SOA Wealth Advisors LLC. raised its position in shares of CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 131 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of several recent research reports. Barclays increased their price target on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. UBS Group reissued an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Jefferies Financial Group lifted their target price on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Mizuho increased their price target on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Finally, The Goldman Sachs Group lifted their price target on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Price Performance

CVS stock opened at $76.64 on Monday. The business’s fifty day moving average price is $78.52 and its 200 day moving average price is $76.87. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15. The company has a market capitalization of $97.50 billion, a PE ratio of 55.53, a P/E/G ratio of 0.80 and a beta of 0.50. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.